Pharmexcil

Industry experts weigh in on the latest tariff move. They highlight limited near-term disruption but caution about long-term risks…

The 11th edition of the International Exhibition on Pharmaceuticals and Healthcare (iPHEX 2025), organised by the Pharmaceuticals…

Pharmexcil reports Indian pharma revenue and EBITDA growth driven by hospitals, diagnostics and exports, reinforcing sector’s…

A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets…

Proactively investing in employee and workplace safety is not just good for employees, but makes smart business sense

While the immediate consequences of these tariffs will likely result in increased costs for essential drugs, the long-term impact…

Bhavin Mukund Mehta, Whole-Time Director at Kilitch Drugs and Vice-Chairman of Pharmexcil, discusses India’s pharma export…

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has expressed urgent concerns over the recent circular issued…

According to the reports, a 7.38 per cent expansion was observed compared to May 2024-25

India’s pharma exports are projected to grow from $27 billion in 2023 to $350 billion by 2047, positioning the nation as a global…